Manulife Financial Corporation reports developments across its international insurance, financial advice, health solutions, and wealth and asset management businesses. The company operates as Manulife in Canada and Asia and primarily as John Hancock in the United States, with news commonly covering insurance distribution, retirement services, investment solutions, customer health and longevity initiatives, and community programs.
Recurring updates also include quarterly and annual results, dividend announcements, annual meeting materials, management information circulars, shareholder voting matters, executive conference participation, and capital actions involving common and preferred shares. News from John Hancock adds detail on U.S. insurance sales, executive benefits, the John Hancock Vitality program, and longevity-focused research and planning tools.
Manulife (NYSE:MFC) selected Akka to operationalize agentic AI within its enterprise AI platform, aiming to strengthen security, reliability, and performance as the platform expands across the business.
The platform is in beta and Manulife expects AI to generate $1 billion+ of enterprise value by 2027, with roughly one‑fifth from efficiency gains.
Manulife Investment Management (MFC) appointed Liam Spillane as Head of Emerging Markets Fixed Income and Senior Portfolio Manager, Emerging Markets Debt effective January 26, 2026. Based in London, he oversees the global Emerging Markets Fixed Income organisation and leads growth and investment performance across the firm's strategies.
Mr. Spillane brings over 30 years of industry experience, including more than 12 years at Aviva Investors where he last served as Head of Emerging Markets Debt.
Manulife (TSX/NYSE: MFC) received TSX approval for a normal course issuer bid to buy up to 42 million common shares (about 2.5% of issued shares). The NCIB runs from Feb 24, 2026 to Feb 23, 2027, with daily purchases capped at 1,483,481 shares (25% of six‑month ADTV). All shares acquired will be cancelled and purchases remain subject to regulatory and capital requirements.
Manulife (TSX/NYSE/PSE: MFC; SEHK: 945) filed its 2025 audited annual financial statements for the year ended December 31, 2025 and the related MD&A with securities regulators, including the Canadian Securities Administrators and the U.S. SEC on Form 40-F.
According to the company, these documents are available online at manulife.com/en/investors/results-and-reports and shareholders can request a free hard copy via the company's website.
Manulife (TSX/NYSE/PSE: MFC; SEHK: 945) declared quarterly dividends on specified non‑cumulative preferred share series. Dividends are payable on or after March 19, 2026 to shareholders of record at the close of business on February 25, 2026.
Declared per‑share amounts range by series from $0.14675 to $0.396875, covering 11 preferred series.
Manulife (MFC) announced a 10.2% increase to its quarterly common shareholders' dividend, rising by 4.5 cents to $0.485 per share. The dividend is payable on and after March 19, 2026 to shareholders of record at the close of business on February 25, 2026.
For the Canadian and U.S. Dividend Reinvestment and Share Purchase Plans, the company will buy common shares on the open market to satisfy reinvested dividends and optional cash purchases; there are no applicable discounts and purchase price will be the average actual cost to buy the shares.
Manulife (TSX/NYSE: MFC) reported record full-year core earnings of $7.5 billion for 2025 and core EPS $4.21, with net income to shareholders of $5.6 billion. The company raised its common dividend by 10.2%, repurchased 3.1% of shares in 2025 and announced a new NCIB to buy ~2.5%.
Other highlights: APE sales +14% to $9,717 million, new business CSM +28%, NBV +18%, remittances $6.4 billion and a LICAT ratio of 136% in 4Q25.
Manulife (TSX/NYSE: MFC) intends to launch a Normal Course Issuer Bid to purchase for cancellation up to 42 million common shares (~2.5% of shares outstanding), subject to Toronto Stock Exchange acceptance. OSFI has approved the NCIB; TSX acceptance and other regulatory approvals remain required.
As at Jan 31, 2026 Manulife had 1,676,743,043 common shares outstanding. The company may buy shares on TSX, NYSE, alternative trading systems, via private purchases under exemptions, or through derivative-based programs; all purchases will be cancelled.
John Hancock (NYSE/TSX: MFC) on Jan 29, 2026 launched Quick Quote, a GenAI underwriting support tool that trims preliminary life-insurance assessments from one day to about 15 minutes. Capacity: designed for >4,000 requests/month; pilot began end-2024 and supported >20,000 cases.
The tool aims to improve underwriting consistency, let underwriters focus on complex cases, and advance Manulife and John Hancock's AI-at-scale strategy while emphasizing responsible integration.
Manulife (TSX/NYSE/PSE: MFC; SEHK: 945) will release its fourth quarter and full year 2025 results after markets close on Wednesday, February 11, 2026. A live webcast and conference call with Manulife's executive leadership team is scheduled for Thursday, February 12, 2026 at 8:00 a.m. ET to discuss results and take analyst questions.
Access details: dial 1-888-317-6003 or 1-647-846-2809 (Passcode: 1741569#); call in 15 minutes early. The webcast and archived materials will be available at the company investor website, and a replay of the call is available until May 12, 2026 (replay dial 1-855-669-9658 or 1-412-317-0088, Passcode: 1920470#).